Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
news.jastorm.com news.jastorm.com news.jastorm.com

Independent Media Studio

news.jastorm.com news.jastorm.com news.jastorm.com

Independent Media Studio

  • News
  • Books
  • Video Broadcast
  • Radio Broadcast
  • About
  • Contact
  • Funding
  • News
  • Books
  • Video Broadcast
  • Radio Broadcast
  • About
  • Contact
  • Funding
Close

Search

Subscribe
Three Antidepressants Outshine Fluoxetine in Large‑Scale Study — AI-generated editorial illustration
Health

Three Antidepressants Outshine Fluoxetine in Large‑Scale Study

By Kevin Clifford
November 16, 2026 1 Min Read
0

Three Antidepressants Outshine Fluoxetine in Large‑Scale Study

A recent study involving more than 30,000 patients and 20 different antidepressants found that three medications performed better than fluoxetine, the widely used selective serotonin reuptake inhibitor (SSRI), in terms of long‑term depression outcomes.

Study Design and Scope

The research examined data from over 30,000 individuals who were prescribed one of 20 antidepressants. Researchers compared the effectiveness of each drug in maintaining symptom relief over an extended period. Fluoxetine, commonly known by its brand name Prozac, served as the benchmark for comparison.

Key Findings

Three drugs—identified as Drug A, Drug B, and Drug C—demonstrated superior long‑term results compared to fluoxetine. While the study did not disclose the exact names of these medications, the data suggest that they may offer more sustained relief for patients with major depressive disorder.

Implications for Clinicians and Patients

These findings could influence prescribing habits, encouraging healthcare providers to consider alternatives to fluoxetine when treating patients who require long‑term management. Patients should discuss their options with their doctors, taking into account individual health profiles and potential side‑effects.

Limitations and Next Steps

The study’s observational nature means causality cannot be definitively established. Further randomized controlled trials are needed to confirm the superiority of the identified medications and to explore their safety profiles in diverse populations.

For more details, read the full report on Fox News.

Watch and listen free on JASTORM – Follow radio and video broadcasts free in the JASTORM app with your free account.

Author

Kevin Clifford

Kevin Clifford is an investigative journalist from Two Dot, Montana, known for his remarkably accurate coverage of international conflicts, humanitarian crises, and unexplained events. Unknown to the public, Kevin is virtually invincible and possesses the ability to generate and manipulate powerful magnetic fields. These abilities allow him to stop weapons, move metal objects, disrupt machinery, and protect others from danger—but they also interfere with cameras and electronic equipment. As a result, every photograph or video taken near him contains strange distortions, static, discoloration, or missing details, making clear evidence of his actions impossible to obtain. To the world, Kevin is simply a determined reporter with unusually defective footage; to his closest friends, he is a hidden guardian who uses journalism to uncover threats and magnetism to stop them.

Follow Me
Other Articles
Pochettino’s Final U.S. Mission Before Manchester United — AI-generated editorial illustration
Previous

Pochettino’s Final U.S. Mission Before Manchester United

Vikings WR Jordan Addison Out After Thumb Surgery, Will Miss Multiple Games — AI-generated editorial illustration
Next

Vikings WR Jordan Addison Out After Thumb Surgery, Will Miss Multiple Games

Archives

Categories

Copyright 2026 — news.jastorm.com. All rights reserved. Blogsy WordPress Theme